A Phase 1/2 Randomised, Observer-Blind Study of the Safety, Reactogenicity, and Immunogenicity of 3 SARS-CoV RNA Vaccine Candidates in Adults Previously Vaccinated and Not Previously Vaccinated Against SARS-CoV-2

  • Funded by National Medical Research Council Singapore
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    N/A
  • Funder

    National Medical Research Council Singapore
  • Principal Investigator

    Jenny Low
  • Research Location

    Singapore
  • Lead Research Institution

    SHHQ
  • Research Priority Alignment

    N/A
  • Research Category

    Vaccines research, development and implementation
  • Research Subcategory

    Phase 1 clinical trial
  • Special Interest Tags

    N/A
  • Study Type

    Clinical
  • Clinical Trial Details

    Clinical Trial, Phase I
  • Broad Policy Alignment

    Pending
  • Age Group

    Unspecified
  • Vulnerable Population

    Unspecified
  • Occupations of Interest

    Unspecified

Abstract